The Umland/Schultz project.  HWI Research Scientists Tim Umland and Wayne Schultz have recently received a 3-year (with an option to extend to a total of 5 years), $1.1M grant from the Department of Defense to study the relationship between conserved protein-protein interactions and successful host-range expansion.
[Learn More]

Collaborators Tom Melendy (Associate Professor, Dept. of Microbiology and Immunology and Dept. of Biochemistry, UB) and Vivian Cody (Principal Research Scientist, HWI) are working to develop a broad-range drug active against human papilloma virus (HPV). Dr. Cody is a subcontractor on a $1.65 million grant awarded to Dr. Melendy by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. [Learn More]

HWI Scientists, Drs. Timothy C. Umland and L. Wayne Schultz - Biomedical scientists collaborating on translational research at two Buffalo institutions are reporting the discovery of a novel, and heretofore unrecognized, set of genes essential for the growth of potentially lethal, drug-resistant bacteria. The study notonly reveals multiple, new drug targets for this human infection, it also suggests that the typical methods of studying bacteria in rich laboratory media may not be the best way to identify much-needed antimicrobial drug targets.[Learn More]